| NCT ID | Title | Status | Phases | Start Date | Completion Date | Primary Completion Date |
|---|---|---|---|---|---|---|
| NCT03886662 | A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) | RECRUITING | PHASE1, PHASE2 | 2019-04 | 2021-07 | 2021-05 |
| NCT01837667 | Phase I Study of LB-100 With Docetaxel in Solid Tumors | COMPLETED | PHASE1 | 2013-02 | 2016-09 | 2016-09 |